Bendroflumethiazide and potassium chloride only product in oral dose form
|
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)
Bendroflumethiazide 2.5 mg and potassium chloride 573 mg prolonged-release oral tablet
Id765644003
StatusDefined
Has manufactured dose formProlonged-release oral tablet
Has unit of presentationTablet
Has BoSSbendroflumethiazide
Has precise active ingredientbendroflumethiazide
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSkaliumchloride
Has precise active ingredientkaliumchloride
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg